Salmeterol/tiotropium bromide - Boehringer Ingelheim
Alternative Names: Tiotropium bromide/salmeterolLatest Information Update: 20 Nov 2014
Price :
$50 *
At a glance
- Originator Boehringer Ingelheim
- Class Antiasthmatics; Antibronchitics; Bronchodilators; Epoxy compounds; Esters; Ethanolamines; Phenethylamines; Small molecules; Thiophenes; Tropanes
- Mechanism of Action Beta 2 adrenergic receptor agonists; Muscarinic M1 receptor antagonists; Muscarinic M3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Chronic obstructive pulmonary disease
Most Recent Events
- 20 Nov 2014 Discontinued - Phase-III for Chronic obstructive pulmonary disease in Belgium and Netherlands (Inhalation)